Enhanced coagulation activation by in vitro lipopolysaccharide challenge in patients with ventricular fibrillation complicating acute myocardial infarction

Journal of Cardiovascular Electrophysiology

Volumn 16, Issue 8, 2005, Pages 858-863

  Kälsch, Thorsten ^a   Elmas, Elif ^a   Nguyen, Xuan Duc ^b   Grebert, Nadine ^a   Wolpert, Christian ^a   Klüter, Harald ^b   Borggrefe, Martin ^a   Haase, Karl Konstantin ^a   Dempfle, Carl Erik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute myocardial infarction; Ventricular fibrillation; Whole blood coagulation

Indexed keywords

LIPOPOLYSACCHARIDE; PADGEM PROTEIN; THROMBOPLASTIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEVICE; FEMALE; FLOW CYTOMETRY; HEART VENTRICLE FIBRILLATION; HUMAN; IN VITRO STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; VISCOMETRY;

ADULT; AGED; BLOOD COAGULATION; CELL AGGREGATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; RETROSPECTIVE STUDIES; VENTRICULAR FIBRILLATION;

EID: 27744549434     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2005.40738.x     Document Type: Article

References (25)

1. Lown B: Sudden cardiac death: The major challenge confronting contemporary cardiology. Am J Cardiol 1979;43:313.
2. Myerburg R, Kessler K, Castellanos A: Sudden cardiac death: Structure, function and time-dependence of risk. Circulation 1992;85:12.
3. Huikuri HV, Castellanos A, Myerburg RJ: Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.
4. Bigger JT Jr, Dresdale FJ, Heissenbuttel RH, Weld FM, Wit AL: Ventricular arrhythmias in ischemic heart disease: Mechanism, prevalence, significance, and management. Prog Cardiovasc Dis 1977;19:255.
5. O'Doherty M, Taylor DI, Quinn E, Vincent R, Chamberlain DA: Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J 1983;286:1405.
6. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349
7. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397.
8. Volpi A, Cavalli A, Santoro L, Negri E, on behalf of the GISSI-2 Investigators: Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction-results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. Am J Cardiol 1998;82:265.
9. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A, for the GUSTO Investigators: Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: Incidence and outcomes. Circulation 1998;98:2567.
10. Huikuri HV, Makikallio TH, Raatikainen MJP, Perkiomaki J, Castellanos A, Myerburg RJ: Prediction of sudden cardiac death: Appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 2003;108:110-115.
11. Kannel WB, Doyle JT, McNamara PM, Quickenton P, Gordon T: Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 1975;51:606.
12. Brezins M, Elyassov S, Elimelech I, Roguin N: Comparison of patients with myocardial infarction with and without ventricular fibrillation. Am J Cardiol 1996;78:948.
13. Yasutake M, Haworth RS, King A, Avkiran M: Thrombin activates the sarcolemmal Na(+)-H+ exchanger. Evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res 1996;79:705-715.
14. Creer MH, Dobmeyer DJ, Corr PB: Amphipathic lipid metabolites and arrhythmias during myocardial ischemia. In Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA: WB Saunders.
15. Pinet C, Le Grand B, John GW, Coulombe A: Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: Implications for ischemic sodium loading. Circulation 2002;106:2098-2103.
16. Markwardt F Jr, Franke T, Glusa E, Nilius B: Pharmacological modification of mechanical and electrical responses of frog heart to thrombin. Arch Pharmacol 1990;341:341-346.
17. Sabri A, Muske G, Zhang H, Pak E, Darrow A, Andrade-Gordon P, Steinberg SF: Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ Research 2000;86:1054-1061.
18. Park TH, McHowat J, Wolf RA, Corr PB: Increased lysophosphatidylcholine content induced by thrombin receptor stimulation in adult rabbit cardiac ventricular myocytes. Cardiovasc Res 1994;28:1263-1268.
19. Derhaschnig U, Reiter R, Knobl P, Baumgartner M, Keen P, Jilma B: Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 2003;102:2093-2098.
20. Yee SB, Hanumegowda UM, Copple BL, Shibuya M, Ganey PE, Roth RA: Endothelial cell injury and coagulation system activation during synergistic hepatotoxicity from monocrotaline and bacterial lipopolysaccharide coexposure. Toxicol Sci 2003;74:203-214.
21. Asakura H, Suga Y, Yoshida T, Ontachi Y, Mizutani T, Kato M, Ito T, Morishita E, Yamazaki M, Miyamoto K, Nakao S: Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagul Fibrinolysis 2003;14:221-228.
22. Ranby M, Ramstrom S, Svensson PO, Lindahl TL: Clotting time by free oscillation rheometry and visual inspection and a viscoelastic description of the clotting phenomenon. Scand J Clin Lab Invest 2003;63:397-406
23. Harb TS, Zareba W, Moss AJ, Ridker PM, Rifai N, Marder VJ, Miller-Watelet L, THROMBO Investigators: Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients. Am J Cardiol 2003;91:1120-1123.
24. Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM: Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002;105:2595-2599.
25. Liuzzo G, Angiolillo DJ, Buffon A, Rizzello V, Colizzi C, Ginnetti F, Biasucci LM, Maseri A: Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina. Circulation 2001;103:2236-2241.